Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey
Ryogo Minamimoto(Graduate School USA), Tomio Inoue(Yamagata University), Hiroshi Fukuda(Tohoku Medical and Pharmaceutical University Hospital), Yutaka Suzuki(The University of Tokyo), Michio Senda(Kyoto University), Sadahiko Nishizawa(Hamamatsu Photonics (Japan)), Kimiichi Uno(Nishida Hospital), Kazuhiro Oguchi(Aizawa Hospital), Masami Nishio, Eriko Tsukamoto, Chio Okuyama(Shiga Medical Center), Takeshi Iinuma, Kengo Ito(National Center for Geriatrics and Gerontology), Seishi Jinnouchi(Memorial), Takashi Terauchi(Families USA), Masami Kawamoto, Rumi Nakashima(Japanese Red Cross Kumamoto Hospital), Tsuyoshi Yoshida(National Defense Academy of Japan)
Cited by 69
Related Papers
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
|NeuroImage|2002|839